目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in This Update?
Information Sources and Methodology
Research Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table Summary : Global Market for Next-Generation Cancer Diagnostics, by Cancer Site, Through 2027
Figure Summary : Global Market for Next-Generation Cancer Diagnostics, by Cancer Site, 2019-2027

Chapter- 3: Market and Technology Background
Overview
Next Generation Sequencing in Personalized Medicine
NGS in Clinical Oncology
Large-Scale Initiatives and Consortia
Liquid Biopsy Technologies
Liquid Biopsy as a Market-Driving Force
Industry
Diagnostics Overview
Arrays and Microfluidics (LOAC) Technologies
Multiplex Conventional Technologies
Polymerase Chain Reaction (PCR) Technology

Chapter- 4: Cancer Diagnostics Market
Forces Driving Growth
Cancer Markets
Market for Next-Generation Cancer Diagnostics by Cancer Site
Market for Next-Generation Cancer Diagnostics by Purpose of Analysis
Market for Next-Generation Cancer Diagnostics by Test Platform
Market for Test Platforms by Cancer Site
Market by Diagnostic Segment

Chapter- 5: Market Breakdown Application by Cancer Site
Overview
Bladder Cancer
Brain Cancer
Breast Cancer
Gynecologic Cancers
Colorectal Cancer
Cancer Unknown Primary
Gastric Cancer
Kidney Cancer
Hematologic Tests: Leukemia and Myeloma
Liver Cancer
Lung Cancer
Hematologic Tests: Lymphomas
Melanoma
Pan-Cancer
Prostate Cancer
Thyroid Cancer

Chapter- 6: Emerging Technologies
Overview
Population Sequencing Programs
Introduction
CRISPR

Chapter- 7: Evaluation of the Market Based on Geographic Region
Overview of the Geographical Distribution of the Market
Overview
North America
Europe
Asia-Pacific
Rest of the World

Chapter- 8: Patents
Table 60 : Select Patent Applications Filed on Next-Generation Cancer Diagnostics Technologies

Chapter- 9: Company Profiles
ABBOTT LABORATORIES
ABBVIE INC.
ADVANCED CELL DIAGNOSTICS INC.
AGILENT TECHNOLOGIES
ARTIVION INC.
BECTON, DICKINSON AND CO.
BENITEC BIOPHARMA LTD.
CALADRIUS BIOSCIENCES
CELGENE CORP.
COMMENCE BIO
DEPUY SYNTHES (J&J)
DRAGERWERK AG & CO. KGAA
EPIC SCIENCES INC.
GENEXINE
GERON
ILLUMINA INC.
IMMUNOCELLULAR THERAPEUTICS
INEX INNOVATIONS EXCHANGE PTE. LTD.
INIVATA LTD.
INTERPACE DIAGNOSTICS LLC
INVIVOSCRIBE INC.
MEDTRONIC PLC
MERCK KGAA
NOVARTIS AG
ONCOCYTE CORP.
ONCOMED PHARMACEUTICALS INC.
PLURISTEM THERAPEUTICS INC.
SILICON BIOSYSTEMS S.P.A
SPHERE FLUIDICS LTD.
THERMO FISHER SCIENTIFIC
VITATEX INC.